FDA Inspection 1202677 — EzriCare, LLC.
The FDA completed an inspection of EzriCare, LLC. on March 21, 2023 in Lakewood, NJ. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- March 21, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lakewood, NJ (United States)